• Linda H Al-ghazali Department of Clinical Analysis, College of Applied Medical Sciences, University of Karbala, Iraq. http://orcid.org/0000-0001-9449-3421
  • Rabab Omran Department of Biology, College of Science, University of Babylon, Iraq




Streptomyces, Antibacterial metabolite, Optimization, Environmental condition



 Objectives: The paper aimed to isolate Streptomyces strain having the ability to produce antibacterial metabolites and optimize some environmental parameters for excellent antibiotic production.

Methods: Different soil samples were collected from extreme environments of desert regions at Karbala Province, Iraq. Actinomycetes were isolated using different media. The primary screening for antibacterial production was accomplished, and the antibacterial activities were tested against pathogenic bacteria, including Escherichia coli, Staphylococcus aureus, Streptococcus agalactiae, and Pseudomonas aeruginosa. The most potent strain was chosen for optimizing some of environmental parameters to increase the bioactive metabolite production. Different parameters were studied such as culture media, temperature, pH, and agitation rate.

Results: About eight Streptomyces strains were isolated from soil samples. All isolates appeared variable levels of antibiotic productions against Gram-positive and negative pathogenic bacteria, and the best one was Streptomyces sp. LHR 9. The antibacterial metabolite production from Streptomyces sp. LHR 9 was affected by various cultural parameters. Glucose soybean meal broth as a fermentation medium at pH 7 yielded the highest antibiotic production under the optimal fermentation conditions, including the temperature at 35°C with 200 rpm (revolution/min) agitation rate and 7 days incubation period.

Conclusion: The Streptomyces sp. LHR 9 showed antibacterial activity against both Gram-positive and negative pathogenic bacteria. It may consider as a potential source of drug production. Further study needs to purification and characterization of antibiotic and analyzes the mechanism for the antimicrobial activity of this bioactive compound.


Download data is not yet available.

Author Biography

Linda H Al-ghazali, Department of Clinical Analysis, College of Applied Medical Sciences, University of Karbala, Iraq.

biology deparament , biotechnology-genetic engineering


Oskay M, Tamer AU, Azeri C. Antibacterial activity of some actinomycetes isolated from farming soils of Turkey. Afr J Biotechnol 2004;3(9):441-6.

Okami Y, Hotta K. Search and discovery of new antibiotics. In: Goodfellow M, Williams ST, Mordarski M, editors. Actinomycetes in Biotechnology. New York: Academic Press Inc.; 1988. p. 33-67.

Pandey B, Ghimire P, Agrawal VP. International Conference on the Great Himalayas: Climate, Health, Ecology, Management and Conservation, Kathmandu, Organized by Kathmandu University and the Aquatic Ecosystem Health and Management Society. Canada; 2004.

Alanis AJ. Resistance to antibiotics: Are we in the post-antibiotic era? Arch Med Res 2005;36(6):697-705.

Enright MC. The evolution of a resistant pathogen - the case of MRSA. Curr Opin Pharmacol 2003;3(5):474-9.

Goodfellow M, Haynes JA. Actinomycetes in marine sediments. In: Ortiz-Ortiz L, Bojalil LF, Yakoleff V, editors. Biological, Biochemical, and Biomedical Aspects of Actinomycetes. New York, USA: Academic Press; 1984. p. 453-72.

Butler MS, Buss AD. Natural products - The future scaffolds for novel antibiotics? Biochem Pharmacol 2006;71(7):919-29.

Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J Nat Prod 2007;70(3):461-77.

Baltz RH. Antimicrobials from actinomycetes: Back to the future. SIM News 2005;55:186-96.

Baltz RH. Antimicrobials from actinomycetes. Back to the future. Microbe 2007;2:125-31.

Williams ST, Goodfellow M, Alderson G, Wellington EM, Sneath PH, Sackin MJ. Numerical classification of Streptomyces and related genera. J Gen Microbiol 1983;129(6):1743-813.

Miyadoh S. Research on antibiotic screening in Japan over the last decade: A producing microorganisms approach. Actinomycetologica 1993;9:100-6.

Gopi R, Ramakrishna R, Rajagopal A. Optimization of culture conditions of Streptomyces rochei (MTCC 10109) for the production of antimicrobial metabolites. Egypt J Biol 2011;13:21-9.

Aman GZ. Studies on Some Actinomycete Isolate from Certain Desert Soil Samples. Ph.D. Thesis. Faculty of Science. Egypt: Al-Azhar University; 2001.

Jonsbu E, McIntyre M, Nielsen J. The influence of carbon sources and morphology on nystatin production by Streptomyces noursei. J Biotechnol 2002;95(2):133-44.

Padma PN, Rao AB, Yadav JS, Reddy G. Optimization of fermentation conditions for production of glycopeptide antibiotic vancomycin by Amycolatopsis orientalis. Appl Biochem Biotechnol 2002;102-103(1-6):395-405.

El-Naggar MY, Hassan MA, Said WY, El-Aassar SA. Effect of support materials on antibiotic MSW2000 production by immobilized Streptomyces violatus. J Gen Appl Microbiol 2003;49(4):235-43.

Sharon SF, Daniel RR, Shenbagarathai R. Optimization of antibiotic productionby marineactinomycetes Streptomyces sp. Int J Pharm Pharm Sci 2014;6(8):506-10.

Kiviharju K, Leisola M, Eerikäinen T. Optimization of Streptomyces peucetius var. Caesius N47 cultivation and epsilon-rhodomycinone production using experimental designs and response surface methods. J Ind Microbiol Biotechnol 2004;31(10):475-81.

Venkateswarlu G, Krishna PS, Rao LV. Production of Rifamycin using Amycolatopsis mediterranei (MTCC14). Bioprocess Biosyst Eng 2004;20:27-30.

Kämpfer P, Order XI. Streptomycetales ord. Nov. In: Goodfellow M, Kampfer P, Busse HJ, Trujillo ME, Suzuki K, Ludwig W, editors. Bergey’s Manual of Systematic Bacteriology. 2nd ed. New York, NY: Whitman; 2012. p. 1446-806.

Gesheva V, Ivanova V, Gesheva R. Effects of nutrients on the production of AK-111-81 macrolide antibiotic by Streptomyces hygroscopicus. Microbiol Res 2005;160(3):243-8.

Karthick L, Kumar KV, Bhaskara RA. Diversity of marine actinomycetes from Nicobar marine sediments and its antifungal activity. Int J Pharm Pharm Sci 2010;2(1):199-203.

Omran R, Kadhem MF. Production, purification, and characterization of bioactive metabolites produced from rare actinobacteria Pseudonocardia alni. Asian J Pharm Clin Res 2016;9:264-72.

Shahrokhi S, Bonjar GH, Saadoun I. Biological control of potato isolate of Rhizoctoniasolani by Streptomyces olivaceus strain 115. Biotechnology 2005;4(2):132-8.

Kavanagh F. Analytical Microbiology. Vol. 2. New York: Aead Press; 1972.

Emerson RL, Whiffen AJ, Bohonos N, Deboer C. Studies on the production of antibiotics by actinomycetes and molds. J Bacteriol 1946;52(3):357-66.

Pavani M, Girija SG, Prabhakar T, Bhavani A, Sravani P. Optimization and production of bioactive metabolite from Streptomyces malaysiesis TMS1a. Int J Pharm Sci Rev Res 2014;25:192-6.

Maataoui H, Iraqui M, Jihani S, Ibnsouda S, Haggoud A. Isolation, characterization and antimicrobial activity of a Streptomyces strain isolated from deteriorated wood. Afr J Microbiol Res 2014;8:1178-86.

Paul AK, Banerjee AK. Determination of optimum conditions for antibiotic production by Streptomyces galbus. Folia Microbiol (Praha) 1983;28(5):397-405.

Singh LS, Mazumder S, Bora TC. Optimization of process parameters for growth and bioactive metabolite produced by a salt-tolerant and alkaliphilic actinomycete, Streptomyces tanashiensis strain A2D. J Mycol Méd 2009;19(4):225-33.

Hassan M, El-Naggar M, Said W. Physiological factors affecting the production of an antimicrobial substance by Streptomyces violatus in batch culture. Egypt J Biol 2001;3:1-10.

Anansiriwattana W, Tanasupawat S, Amnuoypol S, Suwanborirux K. Identification and antimicrobial activities of actinomycetes from soils in Samed Island, and geldamycin from strain PC4-3. Thai J Pharm Sci 2006;30:49-56.

Al-Zahrani S. Studies on the antimicrobial activity of Streptomyces sp. Isolated from Jazan. J Kau Sci 2007;19:127-38.

Ripa FA, Nikkon F, Zaman S, Khondkar P. Optimal conditions for antimicrobial metabolites production from a new Streptomyces sp. RUPA-08PR isolated from Bangladeshi soil. Mycobiology 2009;37(3):211-4.

Raytapadar S, Paul AK. Production of an antifungal antibiotic by Streptomyces aburaviensis 1DA-28. Microbiol Res 2001;155(4):315-23.

Ramesh S, Mathivanan N. Screening of marine actinomycetes isolated from the Bay of Bengal, India for antimicrobial activity and industrial enzymes. World J Microbiol Biotechnol 2009;25:2103-11.

Basilio A, González I, Vicente MF, Gorrochategui J, Cabello A, González A, et al. Patterns of antimicrobial activities from soil actinomycetes isolated under different conditions of pH and salinity. J Appl Microbiol 2003;95(4):814-23.

Mukhtar H, Ijaz S, Ikram-Ul-Haq IS. Production of antitumor antibiotic by Streptomyces capoamus. Pak J Bot 2012;44(1):445-52.

Saha MR, Ripa FA, Islam MZ, Khondkar P. Optimization of conditions and in vitro antibacterial activity of secondary metabolite isolated from Streptomyces sp. MNK7. J Appl Sci Res 2010;6(5):453-9.

Sekhar MC, Krishna ER, Talluri VP, Mohan CH. Optimization of media formulation for bacterial isolate Msb-6. Int J Pharm Chem Biol Sci 2013;3:1066-9.

Narayana KJ, Vijayalakshmi M. Optimization of antimicrobal metabolites production by Streptomyces albidoflavus. Res J Pharm 2008;2:4-7.

Thakur D, BoraTC, Bordoloi GN, Mazumdar S. Influence of nutrition and culturing conditions for optimum growth and antimicrobial metabolite production by Streptomyces sp. 201. J Med Mycol 2009;19:161-7.

Yu J, Liu Q, Liu Q, Liu X, Sun Q, Yan J, et al. Effect of liquid culture requirements on antifungal antibiotic production by Streptomyces rimosus MY02. Bioresour Technol 2008;99(6):2087-91.

Manjula C, Rajaguru P, Muthuselvam M. Screening for antibioticsensitivity of free and immobolized actinomycetes isolated from India. Adv Biol Res 2009;3(3-4):84-8.

Elattal NA, Hamdy AA, Ali AE, Amin MA. Nystatin production by a local Streptmyces sp. Isolated from Egyptian soil. J Pharm Biomed Sci 2011;1(6):128-36.



How to Cite

Al-ghazali, L. H., and R. Omran. “OPTIMIZATION PRODUCTION CONDITIONS OF ANTIBACTERIAL METABOLITE FROM STREPTOMYCES SP”. Asian Journal of Pharmaceutical and Clinical Research, vol. 10, no. 9, Sept. 2017, pp. 386-91, doi:10.22159/ajpcr.2017.v10i9.19243.



Original Article(s)

Most read articles by the same author(s)